Healthcare Costs Prevented Almost 40 Million Americans from Filling Their Prescriptions in 2008

Manhattan ResearchNearly 40 million U.S. adults decided not to fill a prescription medication from a doctor in the past year because of the cost, according to pharmaceutical and healthcare market research company Manhattan Research’s Cybercitizen Health™ v8.0 consumer study and strategic advisory service. The study found that women and patients with neurological and mental health conditions were the most likely to give up their medication due to cost.

For those struggling to afford healthcare, online channels have become increasingly important resources. Over 145 million consumers are online for health, and this year's Cybercitizen Health™ study saw the Internet surpass doctors as the top source for obtaining health and medical information.

Top Condition Groups Who Report Not Filling a Prescription Because of the Cost

1. Fibromyalgia
2. Inflammatory Bowel Disease
3. Generalized Anxiety Disorder
4. Chronic Bronchitis
5. Chronic Pain
6. Acute Pain
7. Adult ADHD
8. Anxiety Disorder/Social Phobia
9. Bipolar Disorder
10. Depression
Among U.S. adults (18+)
Source: Cybercitizen Health™ v8.0 (2008)

"Healthcare costs and accessibility are major barriers for Americans, and many are turning to the Internet as an alternative resource for managing their health and making treatment decisions," said Meredith Abreu Ressi, Vice President of Research at Manhattan Research. "While the Internet is an invaluable health resource for patient education and support, it doesn't replace the expertise of a trained medical professional. Healthcare providers, pharmaceutical companies, and other organizations can use online media to inform consumers of the importance of professional medical attention to their long-term health and to raise awareness of patient assistance programs."

Complimentary "State of eHealth" Report
For those interested in learning the latest trends of consumers using the Internet for health, Manhattan Research offers its "State of eHealth" report. Topics include the evolving consumer media mix, search engines for health information, and patients engaging in Health 2.0. To access the report, visit http://www.manhattanresearch.com/research/white-papers/state-of-ehealth.aspx

About Cybercitizen Health™ v8.0
Cybercitizen Health™ v8.0 was fielded in Q3 2008 among 8,714 U.S. adults (ages 18+). This consumer market research and strategic advisory service focuses on how consumers use new media and technology for health and its impact on treatment and product decisions. For topics and available therapeutic segmentations (100+), visit http://www.manhattanresearch.com/cch

About Manhattan Research
Manhattan Research, a Decision Resources, Inc. company, is a leading market research and advisory services firm for global pharmaceutical and healthcare companies. For more information, visit http://www.manhattanresearch.com.

About Decision Resources, Inc.
Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at http://www.DecisionResourcesInc.com.

Most Popular Now

AstraZeneca to acquire CinCor Pharma to strengthen…

AstraZeneca has entered into a definitive agreement to acquire CinCor Pharma, Inc. (CinCor), a US-based clinical-stage biopharmaceutical company, focused on developing no...

NextPoint Therapeutics announces $80 million Serie…

NextPoint Therapeutics, a biotechnology company developing a new world of precision immuno-oncology, announced today that it raised $80 million in Series B financing co-l...

Time-restricted eating reshapes gene expression th…

Numerous studies have shown health benefits of time-restricted eating including increase in life span in laboratory studies, making practices like intermittent fasting a ...

Incurable liver disease may prove curable

Research led by Associate Professor Duc Dong, Ph.D., has shown for the first time that the effects of Alagille syndrome, an incurable genetic disorder that affects the li...

Scientists develop a cancer vaccine to simultaneou…

Scientists are harnessing a new way to turn cancer cells into potent, anti-cancer agents. In the latest work from the lab of Khalid Shah, MS, PhD, at Brigham and Women’s ...

Bayer to accelerate drug discovery with Google Clo…

Bayer AG and Google Cloud announced a collaboration to drive early drug discovery that will apply Google Cloud's Tensor Processing Units (TPUs), which are custom-develope...

COVID-19 vaccines, prior infection reduce transmis…

Vaccination and boosting, especially when recent, helped to limit the spread of COVID-19 in California prisons during the first Omicron wave, according to an analysis by ...

Study identifies potential new approach for treati…

Targeting iron metabolism in immune system cells may offer a new approach for treating systemic lupus erythematosus (SLE) - the most common form of the chronic autoimmune...

Nanotechnology may improve gene therapy for blindn…

Using nanotechnology that enabled mRNA-based COVID-19 vaccines, a new approach to gene therapy may improve how physicians treat inherited forms of blindness. A collabo...

Acquisition of Neogene Therapeutics completed

AstraZeneca has completed the acquisition of Neogene Therapeutics Inc. (Neogene), a global clinical-stage biotechnology company pioneering the discovery, development and ...

Modified CRISPR-based enzymes improve the prospect…

Many genetic diseases are caused by diverse mutations spread across an entire gene, and designing genome editing approaches for each patient’s mutation would be impractic...

Pfizer expands 'An Accord for a Healthier World' p…

Pfizer Inc. (NYSE: PFE) announced that it has significantly expanded its commitment to An Accord for a Healthier World to offer the full portfolio of medicines and vaccin...